Ellyn Hatstat is currently the Director, Oncology Program Lead at Merck, where they have held this position since 2020. Previously, they worked in various roles in clinical research, including as a Senior Study Manager for Merck Early Oncology Clinical Trials and a Clinical Trial Manager II at ICON plc. Ellyn has also served as an Independent Clinical Research Consultant and held positions at companies such as Execupharm, Wyeth Research, and Brigham and Women's Hospital. Ellyn is pursuing a BS in Biobehavioral Health from Penn State University and an MBA from Boston University - School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices